Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
Depreciation & Amortization
Samsung Biologics Co Ltd
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Samsung Biologics Co Ltd
KRX:207940
|
Depreciation & Amortization
-₩32B
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Depreciation & Amortization
-₩281m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
K
|
Knotus Co Ltd
KOSDAQ:278650
|
Depreciation & Amortization
-₩3.5B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Depreciation & Amortization
-₩5.5B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Depreciation & Amortization
-₩810.7m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Depreciation & Amortization
-₩1.8B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-54%
|
See Also
What is Samsung Biologics Co Ltd's Depreciation & Amortization?
Depreciation & Amortization
-32B
KRW
Based on the financial report for Dec 31, 2023, Samsung Biologics Co Ltd's Depreciation & Amortization amounts to -32B KRW.
What is Samsung Biologics Co Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-17%
Over the last year, the Depreciation & Amortization growth was -53%. The average annual Depreciation & Amortization growth rates for Samsung Biologics Co Ltd have been -53% over the past three years , -17% over the past five years .